Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
sanofi
Press Release
Sep 12, 2023
Ad Scientiam Launches International Study to Assess Disability Progression in Multiple Sclerosis With MSCopilot
Read More
Press Release
Jan 25, 2021
Top Employers Institute Proudly Presents the Global Top Employers 2021
On 25 January, 16 leading organisations will be unveiled as Global Top Employers 2021. These are the organisations that are officially certified as leaders in HR for their outstanding HR strategies and people practices.
Read More
Press Release
Sep 27, 2018
Analysis of Over 1,000 Atopic Dermatitis Patients Highlights Moderate-to-Severe Patient Candidacy for Biologics and Small Molecules and Real-World Treatment Patterns for Patients Treated With Sanofi/Regeneron's Dupixent
Candidacy analysis for pipeline agents reveals that JAK inhibitors, such as Pfizer's PF-0496582, AbbVie's upadacitinib and Incyte's topical ruxolitinib have the most potential upside if approved
Read More
Press Release
Feb 11, 2016
Real Endpoints' RxScorecard™ Predicted Launch Failure of Major New Anti-Cholesterol Drugs
Analysis from 2015 showed that because PCSK9 inhibitors had not proved more than incremental value for most patients, payers would dramatically restrict their usage. Poor Q4 sales show that's exactly what happened.
Read More
Press Release
May 13, 2014
CC Wealth Ltd Tracks Glenmark Pharmaceuticals Ltd
CC Wealth Ltd continues to track the success of Glenmark Pharmaceuticals Ltd as the Indian company prepares to enter the biologic drug market in Europe and the U.S as early as 2017.
Read More
First
Prev
1
Next
Last